In summary, in BM biopsies, we observed variable CCN2 expression in megakaryocytes, a cell type increasingly recognized for its importance in the regulation of the BM microenvironment, including the established role of mutant megakaryocytes in MPN promoting myeloproliferation and fibrosis. The gene discussed is CCN2; the disease is myeloproliferative disorder.